Family Office Of America (FOFA) Research & Development (2021 - 2023)
Family Office Of America (FOFA) reported Research & Development of $1500.0 for Q1 2023, down 87.67% on a YoY basis from $12167.0 in Q1 2022, and down 93.51% sequentially from $23100.0 in Q4 2022.
Family Office Of America (FOFA) Research & Development (2021 - 2023) Analysis & Trends
Family Office Of America (FOFA) has 3 years of Research & Development data on file, last reported at $1500.0 in Q1 2023.
- For the quarter ending Q1 2023, Research & Development fell 87.67% year-over-year to $1500.0; the trailing twelve-month figure through Dec 2023 stood at $1500.0 (down 98.14% YoY), and the FY2023 full-year result was $1500.0, down 98.04% from the prior year.
- Research & Development declined to $1500.0 in Q1 2023, from $23100.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $128479.0 in Q2 2021 to a low of $1500.0 in Q1 2023.
- A 3-year average of $65333.1 and a median of $45418.0 in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development sank 64.65% in 2022 and sank 87.67% in 2023, its largest moves.
- Tracing FOFA's Research & Development over 3 years: stood at $124734.0 in 2021, then slumped by 81.48% to $23100.0 in 2022, then tumbled by 93.51% to $1500.0 in 2023.
- Business Quant data shows FOFA's Research & Development at $1500.0 in Q1 2023, $23100.0 in Q4 2022, and $45418.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1,500.00 |
| Dec 31, 2022 | 23,100.00 |
| Jun 30, 2022 | 45,418.00 |
| Mar 31, 2022 | 12,167.00 |
| Dec 31, 2021 | 124,734.00 |
| Sep 30, 2021 | 121,934.00 |
| Jun 30, 2021 | 128,479.00 |